Oncology 2020: a drug development and approval paradigm

被引：21
|
作者：
Dhingra, K. [1 ]
机构：
[1] KAPital Consulting LLC, Sparta, NJ 07871 USA
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷 / 11期
关键词：
D O I：
10.1093/annonc/mdv353
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2347 / 2350
页数：4
相关论文
共 50 条
  • [21] Tumor growth dynamic modeling in oncology drug development and regulatory approval: Past, present, and future opportunities (vol 9, pg 419, 2020)
    Al-Huniti, Nidal
    Feng, Yan
    Yu, Jingyu
    Lu, Zheng
    Nagase, Mario
    Zhou, Diansong
    Sheng, Jennifer
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (02): : 173 - 173
  • [22] Phase 0 clinical trials in oncology: a paradigm shift for early drug development?
    Takimoto, Chris H.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (04) : 703 - 709
  • [23] Phase zero clinical trials in oncology: a new paradigm for early drug development?
    Takimoto, C. H.
    EJC SUPPLEMENTS, 2006, 4 (12): : 8 - 8
  • [24] Phase 0 clinical trials in oncology: a paradigm shift for early drug development?
    Chris H. Takimoto
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 703 - 709
  • [25] ACCELERATING DRUG DEVELOPMENT AND APPROVAL
    Cole, Patrick
    DRUG NEWS & PERSPECTIVES, 2010, 23 (01) : 37 - 47
  • [26] The dilemma of drug development and approval
    Chabner, BA
    ONCOLOGIST, 2003, 8 (06): : 500 - 500
  • [27] Fda ends 2020 with high drug approval rate
    Challener, Cynthia
    Pharmaceutical Technology, 2021, 45 (01) : 26 - 29
  • [28] Biomarker-Driven Early Clinical Trials in Oncology A Paradigm Shift in Drug Development
    Tan, Daniel S. W.
    Thomas, George V.
    Garrett, Michelle D.
    Banerji, Udai
    de Bono, Johann S.
    Kaye, Stan B.
    Workman, Paul
    CANCER JOURNAL, 2009, 15 (05): : 406 - 420
  • [29] Evaluation and Regulation of Oncology Drug Approval Finding the Right Balance
    Lyman, Gary H.
    JAMA ONCOLOGY, 2016, 2 (06) : 728 - 729
  • [30] Accelerated Approval of Oncology Products: The Food and Drug Administration Experience
    Johnson, John R.
    Ning, Yang-Min
    Farrell, Ann
    Justice, Robert
    Keegan, Patricia
    Pazdur, Richard
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (08) : 636 - 644
12345